Ozempic is semaglutide, and whether a plan pays for it turns on one question before any other: what the prescription is for. The label approves it for blood sugar control in adults with type 2 diabetes, for cutting major cardiovascular risk in that group when they have heart disease, and for kidney protection when they have chronic kidney disease[1]. Weight loss is not on it, which is why a plan’s answer can change with the diagnosis on the claim.
What the maker says about commercial plans
Novo Nordisk states that Ozempic is covered by most commercial insurance plans in the US[2]. It then lists what decides it for any one person: the plan’s formulary, the approved indication, and any prior authorization or step therapy the insurer requires[2]. Step therapy means the plan wants another drug tried first, and prior authorization means your prescriber sends paperwork before the pharmacy can bill the plan.
An employer survey points the same way from the payer’s side. Health plans have generally covered these drugs when they are prescribed for diabetes, KFF reported in its 2025 survey[3]. It also noted that some employers told it they had stopped covering them for weight loss, and a few had tightened coverage even for people with diabetes[3].
| Coverage | Does the plan pay? | Maker's offer that applies |
|---|---|---|
| Commercial plan that covers Ozempic | Usually, for type 2 diabetes, subject to prior authorization or step therapy | Copay card: as little as $25 a month, up to $100 off, for up to 48 months |
| Commercial plan that does not cover it | No | Self-pay: $349 a pen at 0.25 mg, 0.5 mg, 1 mg; $499 at 2 mg |
| Medicare Part D | Most plans list it; cost varies by plan | Copay card excluded; self-pay allowed |
| Medicaid | Medicaid's own drug coverage applies | Copay card excluded; self-pay allowed |
When the prescription is for weight loss
Coverage of GLP-1 drugs used primarily for weight loss is a separate decision in most employer plans. Among firms with 200 or more workers that offer benefits, 16% of those with 200 to 999 workers covered them for weight loss in 2025[3]. The share rose to 30% at 1,000 to 4,999 workers and 43% at 5,000 or more[3]. Of those that did cover them, 34% required a dietitian, case manager, therapist or lifestyle program first[3].
That survey counts GLP-1 drugs as a class, so it does not say which brand a plan lists. The brand approved for weight is Wegovy, with its own coverage rules, set out in is Wegovy covered by insurance. The price gap between the two pens is worked through in Ozempic vs Wegovy cost.
Medicare and Medicaid
Medicare Part D formularies list injectable semaglutide widely. Across every Part D plan, weighted by enrollment, coverage stayed above 90% from 2021 through the third quarter of 2024[4]. Over the same stretch, prior authorization among plans that covered it rose from under 25% before the third quarter of 2023 to 83.6% in the third quarter of 2024[4]. Oral semaglutide followed the same path, reaching 83.0%[4].
Novo Nordisk says most Part D plans cover Ozempic but the cost varies by plan, and Part D enrollees cannot use its copay card[2]. Medicaid runs its own drug coverage, and its enrollees are excluded from the card too[2]. The detail for each program is in does Medicare cover Ozempic and does Medicaid cover Ozempic.
If your plan covers it: the copay card
Commercially insured patients with Ozempic coverage may pay as little as $25 a month, with savings capped at $100 a month for up to 48 months[2]. The card fills the gap between what the plan pays and your copay, so a plan with a high copay can still leave a balance above the floor once the cap is reached.
A month is one box holding one Ozempic pen, the maker’s own definition[2]. Ask the pharmacy whether the card is applied before or after your deductible, since that decides the first few fills of the year.
If it does not: the self-pay fallback
Without coverage, Novo Nordisk’s self-pay price is $349 a pen at 0.25 mg, 0.5 mg, 1 mg and $499 at 2 mg[2]. New patients pay $199 for their first 2 monthly fills at the two starting doses[2]. The full ladder is in Ozempic cost.
Compounded semaglutide is a different product, not a cheaper Ozempic. What it costs, seller by seller, is on the semaglutide price board, the monthly total with fees is on the all-in monthly calculator, and sellers ranked with every fee counted are on the cheapest semaglutide all-in board.
The question to ask your plan
Call the number on your card and ask three things in order: whether Ozempic is on the formulary, whether it needs prior authorization or a step-therapy trial, and which diagnosis codes the plan accepts. The last answer tells you, before your prescriber writes anything, whether the claim will be read as diabetes care or as a weight-loss request.